| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910777424803321 |
|
|
Titolo |
The children's vaccine initiative : continuing activities : a summary of two workshops held September 12-13 and October 25-26, 1994 / / Greg W. Pearson, editor ; Steering Committee on the Children's Vaccine Initiative: Continuing Activities, Division of Health Promotion and Disease Prevention, Institute of Medicine |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C. : , : National Academy Press, , 1995 |
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (x, 55 pages) |
|
|
|
|
|
|
Altri autori (Persone) |
|
PearsonGreg W |
HallCaroline Breese |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Vaccination of children |
Vaccines |
Immunization of children |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Committee chair: Caroline Breese Hall. |
Support for this project was provided by the Agency for International Development. |
A summary of two workshops held September 12-13 and October 25-26, 1994. |
|
|
|
|
|
|
|
|
Nota di contenuto |
|
""The Children's Vaccine Initiative: Continuing Activities""; ""Copyright""; ""Preface""; ""Contents""; ""Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World""; ""INTRODUCTION""; ""ARI AND MENINGOCOCCAL MENINGITIS IN THE DEVELOPING WORLD""; ""DETERMINING VACCINE NEED""; ""OVERCOMING SCIENTIFIC AND TECHNOLOGICAL BARRIERS""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""PROVING VACCINE EFFICACY: THE CHALLENGE OF DEVELOPING-COUNTRY FIELD TRIALS""; ""The Public-/Private-Sector Interface""; ""INTRODUCING AN EFFECTIVE VACCINE"" |
""Involving the U.S. Public and Private Sectors in the CVI""""INTRODUCTION""; ""BRINGING CLARITY TO THE CVI VISION""; ""TRENDS IN THE GLOBAL VACCINE SITUATION""; ""Industry Characteristics""; ""Local Production and Self-Sufficiency""; ""RESHAPING THE EPI""; ""A |
|
|
|
|
|
|
|
|
|
|
ROLE FOR INDUSTRY""; ""Barriers to Participation""; ""FACILITATING GREATER U.S. INVOLVEMENT""; ""Differential Pricing""; ""Technology Transfer""; ""DISCUSSION SUMMARY""; ""Appendix A Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World""; ""FINAL AGENDA""; ""Day 1""; ""Day 2"" |
""WORKSHOP SPEAKERS""""WORKSHOP PARTICIPANTS""; ""Staff""; ""Appendix B Involving the U.S. Public and Private Sectors in the CVI""; ""FINAL AGENDA""; ""Day 1""; ""Involving the U.S. Public and Private Sectors in the CVI""; ""WORKSHOP SPEAKERS""; ""COMMISSIONED PAPER""; ""WORKSHOP PARTICIPANTS""; ""Staff""; ""Appendix C Acronyms and Abbreviations"" |
|
|
|
|
|
| |